Peer Exchange
November 19, 2018 –
Jill Dehlin, RN; Peter Goadsby, MD, PhD; Peter L. Salgo, MD; and Malaika Stoll, MD, MPA, comment on their expectations for providing patients with migraine with coverage of novel treatment options and share their final insights on improving care for patients.
November 19, 2018 –
Jill Dehlin, RN; Peter Goadsby, MD, PhD; and Peter L. Salgo, MD, discuss emerging therapies and their potential role in preventing and treating migraines in the future.
November 12, 2018 –
Peter Goadsby, MD, PhD; Jill Dehlin, RN; Peter L. Salgo, MD; and Malaika Stoll, MD, MPA, explain the importance of real-world data in determining the efficacy of CGRP (calcitonin gene-related peptide) receptor antagonists as treatment for migraine.
November 12, 2018 –
Jill Dehlin, RN; Peter L. Salgo, MD; and Malaika Stoll, MD, MPA, discuss obstacles surrounding coverage for CGRP (calcitonin gene-related peptide) receptor antagonists as migraine therapy.
November 06, 2018 –
Expert panelists Bruce Feinberg, DO; Mark S. Soberman, MD, MBA, FACS; Dana Macher; and Michael Kolodziej, MD, explore the risk of unbridled consolidation leading to the creation of healthcare monopolies.
November 06, 2018 –
Expert panelists Bruce Feinberg, DO; Mark S. Soberman, MD, MBA, FACS; and Michael Kolodziej, MD, discuss the phenomenon of burnout and resilience among oncologists.
November 05, 2018 –
Jill Dehlin, RN; Peter Goadsby, MD, PhD; Peter L. Salgo, MD; and Malaika Stoll, MD, MPA, discuss practical implications for using the gammaCore Neurostimulation Device as a treatment method for migraine.
November 05, 2018 –
Jill Dehlin, RN; Peter Goadsby, MD, PhD; Peter L. Salgo, MD; and Malaika Stoll, MD, MPA, highlight novel treatment options that are being studied in late phases for the treatment of migraine.
October 31, 2018 –
Expert panelists Bruce Feinberg, DO; Dana Macher; and Michael Kolodziej, MD, explore different healthcare payment models.
October 31, 2018 –
Expert panelists Bruce Feinberg, DO; Mark S. Soberman, MD, MBA, FACS; Michael Kolodziej, MD; and Dana Macher discuss oncology care within integrated delivery networks.
